Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Chemoimmunotherapy”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Looking for participantsNCT06219980
What this trial is testing

SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx

Who this might be right for
SBRT
Sun Yat-sen University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07121374
What this trial is testing

NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study

Who this might be right for
Pleural Epithelioid MesotheliomaMesothelioma; PleuraNeoadjuvant Chemoimmunotherapy
University Hospital, Antwerp 37
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Testing effectiveness (Phase 2)Looking for participantsNCT06039631
What this trial is testing

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Who this might be right for
Larynx CancerHypopharyngeal Cancer
Fudan University 82
Large-scale testing (Phase 3)Looking for participantsNCT06907602
What this trial is testing

Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06289062
What this trial is testing

Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant ChemoimmunotherapyFertility Preservation
Tongji Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04943029
What this trial is testing

Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07400094
What this trial is testing

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and NeckLaryngeal NeoplasmsOral Cavity Neoplasm
National Medical Research Radiological Centre of the Ministry of Health of Russia 50
Testing effectiveness (Phase 2)Looking for participantsNCT06709885
What this trial is testing

HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon Cancer

Who this might be right for
Colon Adenocarcinoma
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05605535
What this trial is testing

Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialOvarian CancerFallopian Tube Neoplasms+2 more
CanariaBio Inc. 88
Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40
Not applicableNot Yet RecruitingNCT07092449
What this trial is testing

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

Who this might be right for
Gastroesophageal JunctionGastric / Gastroesophageal Junction AdenocarcinomaNeoadjuvant Chemoimmunotherapy+1 more
Tang-Du Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353476
What this trial is testing

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Post Surgical
Shanghai Zhongshan Hospital 38
Testing effectiveness (Phase 2)Looking for participantsNCT06421376
What this trial is testing

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerImmunotherapyInduction Therapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT07127497
What this trial is testing

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Pathological Complete ResponseRectal CancerNeoadjuvant Chemoimmunotherapy
The First Affiliated Hospital of Anhui Medical University 50
Not applicableActive Not RecruitingNCT06243679
What this trial is testing

The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC

Who this might be right for
Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University 100
Not applicableLooking for participantsNCT06436040
What this trial is testing

Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma

Who this might be right for
Tumor MicroenvironmentLung Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Tang-Du Hospital 40
Not applicableUnknownNCT06267144
What this trial is testing

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
The First Hospital of Jilin University 20
Not applicableNot Yet RecruitingNCT06591910
What this trial is testing

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Unresectable Stage III Non-small-cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 50
Load More Results